The FDA today reported that so far, it has found no signs of heart risks associated with long-term use of the drugs Prilosec and Nexium. disease (GERD) and stomach and duodenal ulcers. Prilosec is ...

Add Yahoo as a preferred source to see more of our stories on Google. Pharmaceutical company AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney ...

FDA officials say it will need three months to thoroughly analyze data on possible cardiac risk associated with Nexium and Prilosec, both proton pump inhibitors used to treat heartburn and reflux ...

(RTTNews) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Tuesday that it has entered into settlement agreements in the product liability litigations related to Nexium and Prilosec. The ...

Health Canada says it's reviewing new safety data on AstraZeneca's heartburn drugs Nexium and Prilosec. The preliminary data shows patients may have had more heart attacks and other cardiac problems ...

The US Food and Drug Administration (FDA) today issued its final assessment of two small, open, long-term, clinical studies in patients with gastro-esophageal reflux disease (GERD), comparing ...

Oct 3 (Reuters) - British drugmaker AstraZeneca AZN.L on Tuesday said it will pay $425 million to settle product liability litigations against prescription-only acid-reflux medicine Nexium and ...

ROCKVILLE, Md. The Food and Drug Administration on Monday affirmed that long-term use of either of the proton-pump inhibitors Prilosec or Nexium was not linked to any increase in the risk of heart ...

SATURDAY, Aug. 19, 2017 -- Widely used heartburn drugs called proton pump inhibitors do not appear to increase Alzheimer's disease risk, according to a new study. Prilosec, Nexium and Prevacid are ...

WASHINGTON, Dec 10 (Reuters) - U.S. regulators gave a clean bill of health to AstraZeneca Plc's Prilosec and Nexium on Monday, saying they found no evidence of an increased risk of heart problems from ...